Procter & Gamble Hygiene and Health Care Limited (BOM:500459)
India · Delayed Price · Currency is INR 13,096
+41 (0.31%)
At close: Aug 29, 2025
BOM:500459 Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2016 - 2020 |
| 44,992 | 42,057 | 39,179 | 39,009 | 35,741 | Upgrade | |
Revenue Growth (YoY) | 6.98% | 7.35% | 0.43% | 9.14% | 19.06% | Upgrade |
Cost of Revenue | 16,805 | 16,292 | 16,710 | 15,675 | 11,651 | Upgrade |
Gross Profit | 28,187 | 25,765 | 22,469 | 23,335 | 24,091 | Upgrade |
Selling, General & Admin | 8,184 | 7,750 | 6,233 | 6,785 | 7,130 | Upgrade |
Other Operating Expenses | 8,230 | 7,893 | 7,469 | 8,129 | 7,944 | Upgrade |
Operating Expenses | 16,840 | 16,208 | 14,286 | 15,443 | 15,551 | Upgrade |
Operating Income | 11,348 | 9,557 | 8,183 | 7,892 | 8,540 | Upgrade |
Interest Expense | -118.53 | -202.5 | -52.6 | -59.4 | -13.7 | Upgrade |
Interest & Investment Income | 384.8 | 452.2 | 362.1 | 242.9 | 322.9 | Upgrade |
Currency Exchange Gain (Loss) | -52.13 | -37.3 | -43.7 | -70.1 | -10.9 | Upgrade |
Other Non Operating Income (Expenses) | 23.33 | 70.3 | 43.7 | 0.3 | 70.9 | Upgrade |
EBT Excluding Unusual Items | 11,585 | 9,839 | 8,493 | 8,006 | 8,909 | Upgrade |
Merger & Restructuring Charges | -43.47 | -135.6 | - | - | -8.6 | Upgrade |
Gain (Loss) on Sale of Assets | -3.07 | -55.4 | -8.3 | -17.6 | -18.5 | Upgrade |
Asset Writedown | 89.73 | -130.3 | - | - | -76.4 | Upgrade |
Other Unusual Items | -132.93 | -126.1 | -89.6 | -86.6 | -106.9 | Upgrade |
Pretax Income | 11,495 | 9,392 | 8,395 | 7,901 | 8,699 | Upgrade |
Income Tax Expense | 3,008 | 2,642 | 1,613 | 2,144 | 2,181 | Upgrade |
Net Income | 8,488 | 6,750 | 6,781 | 5,758 | 6,518 | Upgrade |
Net Income to Common | 8,488 | 6,750 | 6,781 | 5,758 | 6,518 | Upgrade |
Net Income Growth | 25.74% | -0.46% | 17.78% | -11.67% | 50.50% | Upgrade |
Shares Outstanding (Basic) | 32 | 32 | 32 | 32 | 32 | Upgrade |
Shares Outstanding (Diluted) | 32 | 32 | 32 | 32 | 32 | Upgrade |
EPS (Basic) | 261.48 | 207.95 | 208.91 | 177.37 | 200.79 | Upgrade |
EPS (Diluted) | 261.48 | 207.95 | 208.91 | 177.37 | 200.79 | Upgrade |
EPS Growth | 25.74% | -0.46% | 17.78% | -11.67% | 50.50% | Upgrade |
Free Cash Flow | 7,176 | 4,253 | 7,813 | 5,233 | 8,315 | Upgrade |
Free Cash Flow Per Share | 221.06 | 131.03 | 240.70 | 161.21 | 256.16 | Upgrade |
Dividend Per Share | 233.333 | 195.000 | 185.000 | 160.000 | 165.000 | Upgrade |
Dividend Growth | 19.66% | 5.41% | 15.63% | -3.03% | 57.14% | Upgrade |
Gross Margin | 62.65% | 61.26% | 57.35% | 59.82% | 67.40% | Upgrade |
Operating Margin | 25.22% | 22.72% | 20.89% | 20.23% | 23.89% | Upgrade |
Profit Margin | 18.87% | 16.05% | 17.31% | 14.76% | 18.24% | Upgrade |
Free Cash Flow Margin | 15.95% | 10.11% | 19.94% | 13.41% | 23.27% | Upgrade |
EBITDA | 11,763 | 10,111 | 8,756 | 8,407 | 9,002 | Upgrade |
EBITDA Margin | 26.14% | 24.04% | 22.35% | 21.55% | 25.19% | Upgrade |
D&A For EBITDA | 415.07 | 553.8 | 572.4 | 514.9 | 461.8 | Upgrade |
EBIT | 11,348 | 9,557 | 8,183 | 7,892 | 8,540 | Upgrade |
EBIT Margin | 25.22% | 22.72% | 20.89% | 20.23% | 23.89% | Upgrade |
Effective Tax Rate | 26.16% | 28.13% | 19.22% | 27.13% | 25.07% | Upgrade |
Revenue as Reported | 45,490 | 42,580 | 39,585 | 39,252 | 36,135 | Upgrade |
Advertising Expenses | - | 5,310 | 4,084 | 4,546 | 5,030 | Upgrade |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.